GERN

Conviction 43HealthcareScan · Mon, Aug 10, 2026

GERN$1.47-0.68%

ResistanceSupportVol 14

Vol MA14 12.47M

May 11May 28Jun 16Jul 6Jul 23Aug 10

GERON CORPPHARMACEUTICAL PREPARATIONSwww.geron.com ↗

Price1.47

Change-0.68%

Gap-2.70%

Rel volume0.79×

Avg volume10.72M

Avg $ vol15.4M

SMA 201.43

SMA 501.34

SMA 2001.40

Price vs 50+9.50%

Price vs 200+4.64%

MA stackmixed

50/200 cross—

Supertrendup · 1.26

RSI (14)54

MACD hist0.01

MACD crossbull · 2d

Stoch %K / %D61 / 70

ADX (14)21

+DI / −DI29 / 22

RSI divergence—

MACD divergence—

ATR %+6.77%

ADR %6.26%

52w high1.95

52w low1.07

From 52w high-24.62%

Above 52w low+37.38%

New 52w highNo

SqueezeOff

Bollinger width22.55%

%B0.63

Donchian pos60.98%

Donchian high1.63

Donchian low1.22

AVWAP (52w high)1.50

vs AVWAP high-1.74%

AVWAP (52w low)1.46

vs AVWAP low+0.62%

OBV trendDown

Chaikin MF (20)0.02

Today vs 20d0.79×

Avg vol (14d)12.47M

Avg vol (20d)10.72M

Avg $ vol (20d)15.4M

Market cap944.44M

RS 3m (vs SPY)-4.33%

RS 6m (vs SPY)-12.74%

RS line new highNo

Trend template6/8

Technical rank48.1

1 week+14.84%

1 month-2.00%

3 months+5.76%

6 months-3.92%

1 year+13.08%

YTD+11.36%

P/E-11.31

P/B4.32

P/S—

P/FCF-8.45

EPS-0.1300

Div yield—

ROE-38.20%

ROA-16.09%

Debt/Eq0.88

Current6.92

EV/EBITDA-15.76

Gross margin—

Net margin—

Rev growth-60.23%

EPS growth52.17%

Price target4.33

Target upside194.56%

Analyst ratingBuy

Institutional84.88%

Ent. value1.07B

Revenue57.48M

Net income-16.68M

Gross profit—

Free cash flow-111.72M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out641.52M

Employees258

ListedWed, Jul 31, 1996

Free float625.8M

Float %97.6%

Short interest69.92M

Days to cover6.8d

Short volume50.2%

Squeeze score54 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.02 vs −$0.01

Last surprise-100.0% miss

Setup gradeD

Conviction43 / 100

Pattern quality—

Tech rank48.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.63

Support1.24

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GERN

All disclosures →

No recent disclosed trades by Congress in GERN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GERN · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Bir Dawn Carter Director · Stock Option (right to buy) · 2026-05-20	Grant	220K	$0	2026-05-20	2026-05-26
O'Farrell Elizabeth G. Director · Stock Option (right to buy) · 2026-05-20	Grant	220K	$0	2026-05-20	2026-05-26
Molineaux Susan Director · Stock Option (right to buy) · 2026-05-20	Grant	220K	$0	2026-05-20	2026-05-26
Spiegel Robert J. Director · Stock Option (right to buy) · 2026-05-20	Grant	220K	$0	2026-05-20	2026-05-26
McDonald John F Director · Stock Option (right to buy) · 2026-05-20	Grant	220K	$0	2026-05-20	2026-05-26
Williams Timothy EVP and Chief Legal Officer · Stock Option (Right to Buy) · 2026-04-13	Grant	2.5M	$0	2026-04-13	2026-04-14

SEC filings

EDGAR filings in GERN · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.